HDAC6 regulates cigarette smoke-induced endothelial barrier dysfunction and lung injury
HDAC6 regulates cigarette smoke-induced endothelial barrier dysfunction and lung injury
批准号:
9285844
负责人:
Qing Lu
金额:
$32.18万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2020-05-31
关键词:
Acute Lung InjuryAddressAdult Respiratory Distress SyndromeAdverse effectsAffectAnimal ModelBacterial InfectionsBindingBlood CirculationBlood VesselsCell Culture TechniquesCell physiologyCessation of lifeCharacteristicsDataDeacetylaseDeacetylationDiseaseDynaminEndothelial CellsEndotheliumEpidemiologyFunctional disorderGoalsHDAC6 geneHumanImpairmentIn VitroIndividualInfectionInjuryKnockout MiceLifeLinkLungMaintenanceMediatingMediator of activation proteinMicroRNAsMicrotubule-Associated ProteinsMicrotubulesMissionMitochondriaMitochondrial DNAModelingMolecularMorbidity - disease rateOrganOxidantsPatternPermeabilityPhosphorylationPopulationPredispositionPreventiveProteinsPseudomonasPseudomonas InfectionsPseudomonas aeruginosaPublic HealthQuality ControlReactive Oxygen SpeciesResearchResearch PersonnelRespiratory Tract InfectionsRisk FactorsRoleSmokerSyndromeTechnologyTherapeuticTubulinUnited States National Institutes of Healthalpha Tubulincigarette smoke-inducedcigarette smokingclinical riskenvironmental tobacco smoke exposureepidemiology studyin vivoinnovationinsightlung injurymitochondrial dysfunctionmortalitynovelnovel therapeutic interventionnovel therapeuticsoxidationpre-clinicalprematurepreventsegregation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cigarette smoke (CS) affects 1 billion people worldwide and causes 6 million premature deaths from
associated diseases each year. Acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) is a life-
threatening condition with 40% mortality. Emerging epidemiology studies have shown that CS predisposes
lungs to infections and increases the likelihood of ALI/ ARDS. However, the mechanism of adverse effects of
CS on ALI is unknown. There is an urgent need for strategies to prevent and treat ALI/ ARDS in smokers. The
objectives of this application is to use human lung microvascular endothelial cells (LMVEC) and preclinical
animal models to identify mechanisms by which CS impairs pulmonary endothelial barrier function and
increases vulnerability to ALI after bacterial infection and to develop strategies to prevent and restore
endothelial barrier function and ALI in susceptible populations. This study uses state-of-art technologies and
comprehensive approaches to address a central hypothesis that CS increases endothelial cell permeability
and predisposes lungs to ALI after infection by a mechanism in which oxidants from CS and mitochondria
cause Akt oxidation and subsequent GSK3β-dependent activation of histone deacetylase 6 (HDAC6), this
results in microtubule deacetylation, leading to translocation of dynamin-related protein (Drp)1 to mitochondria,
culminating in mitochondrial fission and dysfunction and subsequent release of mitochondrial damage-
associated molecular patterns (mtDAMPs). Aim 1: We will first determine the role of HDAC6 in CS priming for
ALI after Pseudomonas aeruginosa infection by using global HDAC6 knockout mice, endothelium-specific
lentiviral HDAC6 miRNA silencing in vivo, and LMVEC isolated from HDAC6 knockout mice; we will then
determine the mechanism by which CS exposure leads to HDAC6 activation. Aim 2: We will determine the
role of HDAC6 in CS-induced mitochondrial fission and dysfunction and their roles in mediating increased
endothelial permeability and priming for ALI after P. aeruginosa infection. We will first characterize the effects
of CS exposure on Drp1 translocation and on mitochondrial fission, fusion, function, and release of mtDNA in
vitro and in vivo; we will then determine the effect of blocking HDAC6 or α-tubulin deacetylation on the adverse
effects of CS on mitochondria in vitro and in vivo; finally, we will determine the roles of mitochondrial fission,
mitochondrial ROS and mtDAMPs in CS-induced increased endothelial permeability in vitro and CS priming for
ALI in vivo. This study will provide innovative insights into the effect of CS on lung endothelial barrier function.
Establishment of the links among HDAC6, mitochondrial fission and mtDAMPs may result in new therapeutic
approaches to CS-induced vascular injury in the lung and potentially also in the systemic circulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Computational Efficient Statistical Tools for Analyzing Substance Dependence Sequencing Data
-
批准号:9922519
-
项目类别:
-
资助金额:$41.22万
-
财政年份:2019
-
负责人:Qing Lu
-
依托单位:
Computational Efficient Statistical Tools for Analyzing Substance Dependence Sequencing Data
-
批准号:10166816
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2019
-
负责人:Qing Lu
-
依托单位:
Methods and Software for High-dimensional Risk Prediction Research
-
批准号:9975910
-
项目类别:
-
资助金额:$25.54万
-
财政年份:2018
-
负责人:Qing Lu
-
依托单位:
Methods and Software for High-dimensional Risk Prediction Research
-
批准号:9924898
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2018
-
负责人:Qing Lu
-
依托单位:
Methods and Software for High-dimensional Risk Prediction Research
-
批准号:10170422
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2018
-
负责人:Qing Lu
-
依托单位:
Computational Efficient Statistical Tools for Analyzing Substance Dependence Sequencing Data
-
批准号:9453828
-
项目类别:
-
资助金额:$45.47万
-
财政年份:2017
-
负责人:Qing Lu
-
依托单位:
Gene-Gene/Gene-Environment Interactions Associated with Nicotine Dependence
-
批准号:8620634
-
项目类别:
-
资助金额:$16.81万
-
财政年份:2013
-
负责人:Qing Lu
-
依托单位:
Gene-Gene/Gene-Environment Interactions Associated with Nicotine Dependence
-
批准号:9008033
-
项目类别:
-
资助金额:$16.34万
-
财政年份:2013
-
负责人:Qing Lu
-
依托单位:
Gene-Gene/Gene-Environment Interactions Associated with Nicotine Dependence
-
批准号:8443232
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2013
-
负责人:Qing Lu
-
依托单位:
High-dimensional Statistical Genetic Approach for Family-based Orofacial Clefts
-
批准号:8227059
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2012
-
负责人:Qing Lu
-
依托单位:
High-dimensional Statistical Genetic Approach for Family-based Orofacial Clefts
-
批准号:8460488
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2012
-
负责人:Qing Lu
-
依托单位:
Adenosine and Lung Endothelial Injury
-
批准号:8465677
-
项目类别:
-
资助金额:$22.12万
-
财政年份:--
-
负责人:Qing Lu
-
依托单位:
Adenosine and Lung Endothelial Injury
-
批准号:8735962
-
项目类别:
-
资助金额:$24.55万
-
财政年份:--
-
负责人:Qing Lu
-
依托单位:
Adenosine and Lung Endothelial Injury
-
批准号:8854110
-
项目类别:
-
资助金额:$24.37万
-
财政年份:--
-
负责人:Qing Lu
-
依托单位:
海外基金